BlackRock Advisors’s Immunic IMUX Stock Holding History

BlackRock Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$51K	Buy	29 +1	+4%	+$2.19K	﹤0.01%	3254
2016 Q3	$69K	Hold	28	–	–	﹤0.01%	3155
2016 Q2	$70K	Buy	28 +3	+12%	+$9.86K	﹤0.01%	3119
2016 Q1	$89K	Hold	25	–	–	﹤0.01%	2969
2015 Q4	$113K	Sell	25 -6	-19%	-$19.6K	﹤0.01%	2868
2015 Q3	$51K	Buy	31 +7	+29%	+$35K	﹤0.01%	3314
2015 Q2	$199K	Buy	24 +16	+200%	+$153K	﹤0.01%	2792
2015 Q1	$83K	Buy	8 +1	+14%	+$9.19K	﹤0.01%	3118
2014 Q4	$70K	Buy	7 +1	+17%	+$7.7K	﹤0.01%	3194
2014 Q3	$45K	Hold	6	–	–	﹤0.01%	3291
2014 Q2	$62K	Buy	+6	New	+$42.1K	﹤0.01%	3216

Other funds holding IMUX

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock Advisors's IMUX Position: Q4 2016 in Review

BlackRock Advisors increased its Immunic (IMUX) stake by 3.6% in Q4 2016, buying an estimated $2.19K and bringing the position to 29 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #3254.

BlackRock Advisors first reported a position in IMUX in Q2 2014 and has held it in 11 quarters since. The position peaked at $199K in Q2 2015. 55 funds tracked by Wall St. Rank hold IMUX as of Q4 2016.

BlackRock Advisors held 29 shares of Immunic worth $51K as of Q4 2016.
BlackRock Advisors bought 1 Immunic share in Q4 2016, an estimated $2.19K.
Immunic made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3254 holding.
BlackRock Advisors first reported a position in Immunic in Q2 2014 and has held it in 11 quarters since.
BlackRock Advisors's Immunic position peaked at $199K in Q2 2015.
55 funds tracked by Wall St. Rank held Immunic as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.